Cann Group Limited (CAN.AX)
ASX · AUD · Healthcare · Drug Manufacturers - Specialty & Generic
A$0.005 (+0.00%) as of
Key statistics
- Market cap
- 8.30M
- P/E (TTM)
- 0.25
- Forward P/E
- 0.02
- EPS (TTM)
- 0.0200
- Dividend yield
- 0.00%
- 52-week range
- 0.0020 – 0.0140
- Beta
- 0.09
- Revenue (TTM)
- 9.65M
- Profit margin
- 213.66%
- Volume
- 231.49k
About Cann Group Limited
Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Mildura, VIC, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.